Survival After Breast-Conserving Surgery Compared with that After Mastectomy in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery?

(2020) Oriana Petruolo et al.   ANNALS OF SURGICAL ONCOLOGY

Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study

(2020) Emily Heer et al.   Lancet Global Health

Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study

(2020) Janine M. Simons et al.   BREAST CANCER RESEARCH AND TREATMENT

Breast-conservation Therapy After Neoadjuvant Chemotherapy Does Not Compromise 10-Year Breast Cancer–specific Mortality

(2018) Renee L. Arlow et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy

(2018) Waqar Haque et al.   BREAST CANCER RESEARCH AND TREATMENT

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

(2018) Bernard Asselain et al.   LANCET ONCOLOGY

Perspectives on preoperative systemic treatment and breast conservative surgery: One step forward or two steps back?

(2018) I.T. Rubio et al.   BREAST

Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients

(2017) Mirelle Lagendijk et al.   INTERNATIONAL JOURNAL OF CANCER

10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study

(2016) Marissa C van Maaren et al.   LANCET ONCOLOGY

Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy

(2016) Sarah S. Mougalian et al.   JAMA Oncology

Survival in stage I–III breast cancer patients by surgical treatment in a publicly funded health care system

(2015) S. Fisher et al.   ANNALS OF ONCOLOGY

Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008

(2015) Olaf Johan Hartmann-Johnsen et al.   ANNALS OF SURGICAL ONCOLOGY

Comparative effectiveness study of breast-conserving surgery and mastectomy in the general population: A NCDB analysis

(2015) Kai Chen et al.   Oncotarget

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

(2014) EBCTCG (Early Breast Cancer Trialists' Collaborative Group)   LANCET

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

(2014) Patricia Cortazar et al.   LANCET

Effect of Breast Conservation Therapy vs Mastectomy on Disease-Specific Survival for Early-Stage Breast Cancer

(2014) Shailesh Agarwal et al.   JAMA Surgery

Impact of Chemotherapy Sequencing on Local-Regional Failure Risk in Breast Cancer Patients Undergoing Breast-Conserving Therapy

(2013) Elizabeth A. Mittendorf et al.   ANNALS OF SURGERY

Breast-Conserving Surgery After Tumor Downstaging by Neoadjuvant Chemotherapy is Oncologically Safe for Stage III Breast Cancer Patients

(2013) Hee-Chul Shin et al.   ANNALS OF SURGICAL ONCOLOGY

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Survival after lumpectomy and mastectomy for early stage invasive breast cancer

(2013) E. Shelley Hwang et al.   CANCER

Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer

(2013) Jung Hoon Cho et al.   JOURNAL OF SURGICAL ONCOLOGY

Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy

(2012) Nehmat Houssami et al.   EUROPEAN JOURNAL OF CANCER

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

(2012) Gunter von Minckwitz et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial

(2012) Saskia Litière et al.   LANCET ONCOLOGY

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY

Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Using MR Imaging and Quantitative1H MR Spectroscopy

(2009) Hyeon-Man Baek et al.   RADIOLOGY

Neoadjuvant Chemotherapy in Invasive Breast Cancer Results in a Lower Axillary Lymph Node Count

(2008) Julie Bélanger et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy

(2008) Uma Sharma et al.   NMR IN BIOMEDICINE